{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:05:27Z","timestamp":1768093527349,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Association Strumpell Lorrain"},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014865","name":"Fondation maladies rares","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014865","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Enroll HD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>VPS13D is a large ubiquitin-binding protein playing an essential role in mitophagy by regulating mitochondrial fission. Recently, <jats:italic>VPS13D<\/jats:italic> biallelic pathogenic variants have been reported in patients displaying variable neurological phenotypes, with an autosomic recessive inheritance.<\/jats:p>\n                <jats:p>The objectives of the study were to determine the genetic etiology of a patient with early onset sporadic progressive spastic ataxia, and to investigate the pathogenicity of <jats:italic>VPS13D<\/jats:italic> variants through functional studies on patient\u2019s skin fibroblasts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 51-year-old patient with spastic ataxia, with an acute onset of the disease at age 7. Walking difficulties slowly worsened over time, with the use of a wheelchair since age 26. We have used trio-based whole-exome sequencing (WES) to identify genes associated with spastic ataxia. The impact of the identified variants on mitochondrial function was assessed in patient\u2019s fibroblasts by imaging mitochondrial network and measuring level of individual OXPHOS complex subunits. Compound heterozygous variants were identified in <jats:italic>VPS13D<\/jats:italic>: c.946C\u2009&gt;\u2009T, p.Arg316* and c.12416C\u2009&gt;\u2009T, p.(Ala4139Val). Primary fibroblasts obtained from this patient revealed an altered mitochondrial morphology, and a decrease in levels of proteins from complex I, III and IV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings confirmed implication of <jats:italic>VPS13D<\/jats:italic> in spastic ataxia and provided further support for mitochondrial defects in patient\u2019s skin fibroblasts with <jats:italic>VPS13D<\/jats:italic> variants. This report of long-term follow up showed a slowly progressive course of the spastic paraplegia with cerebellar features. Furthermore, the performed functional studies could be used as biomarker helping diagnosis of <jats:italic>VPS13D<\/jats:italic>-related neurological disorders when molecular results are uneasy to interpret.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02553-0","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T07:02:43Z","timestamp":1644649363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Whole-exome sequencing confirms implication of VPS13D as a potential cause of progressive spastic ataxia"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3890-0632","authenticated-orcid":false,"given":"Christelle M.","family":"Durand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00e9","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Delleci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Coupry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Goizet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelien","family":"Trimouille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,12]]},"reference":[{"key":"2553_CR1","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1016\/j.cub.2017.12.017","volume":"28","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhang H. Mitophagy: Vps13D couples mitochondrial fission and Autophagic clearance. Curr Biol CB. 2018;28:R66\u20138.","journal-title":"Curr Biol CB."},{"key":"2553_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cub.2017.11.064","volume":"28","author":"AL Anding","year":"2018","unstructured":"Anding AL, Wang C, Chang T-K, Sliter DA, Powers CM, Hofmann K, et al. Vps13D encodes a ubiquitin-binding protein that is required for the regulation of mitochondrial size and clearance. Curr Biol CB. 2018;28:287\u2013295.e6.","journal-title":"Curr Biol CB"},{"key":"2553_CR3","doi-asserted-by":"publisher","first-page":"e1009731","DOI":"10.1371\/journal.pgen.1009731","volume":"17","author":"R Insolera","year":"2021","unstructured":"Insolera R, L\u0151rincz P, Wishnie AJ, Juh\u00e1sz G, Collins CA. Mitochondrial fission, integrity and completion of mitophagy require separable functions of Vps13D in Drosophila neurons. PLoS Genet. 2021;17:e1009731.","journal-title":"PLoS Genet"},{"key":"2553_CR4","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1091\/mbc.E21-03-0097","volume":"32","author":"Y Du","year":"2021","unstructured":"Du Y, Wang J, Xiong J, Fang N, Ji W-K. VPS13D interacts with VCP\/p97 and negatively regulates endoplasmic reticulum-mitochondria interactions. Mol Biol Cell. 2021;32:1474\u201386.","journal-title":"Mol Biol Cell"},{"key":"2553_CR5","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41467-021-21525-5","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Fang N, Xiong J, Du Y, Cao Y, Ji W-K. An ESCRT-dependent step in fatty acid transfer from lipid droplets to mitochondria through VPS13D-TSG101 interactions. Nat Commun. 2021;12:1252.","journal-title":"Nat Commun"},{"key":"2553_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/hmg\/ddz318","volume":"29","author":"SK Dziurdzik","year":"2020","unstructured":"Dziurdzik SK, Bean BDM, Davey M, Conibear E. A VPS13D spastic ataxia mutation disrupts the conserved adaptor-binding site in yeast Vps13. Hum Mol Genet. 2020;29:635\u201348.","journal-title":"Hum Mol Genet"},{"key":"2553_CR7","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1091\/mbc.e16-02-0112","volume":"27","author":"J-S Park","year":"2016","unstructured":"Park J-S, Thorsness MK, Policastro R, McGoldrick LL, Hollingsworth NM, Thorsness PE, et al. Yeast Vps13 promotes mitochondrial function and is localized at membrane contact sites. Mol Biol Cell. 2016;27:2435\u201349.","journal-title":"Mol Biol Cell"},{"key":"2553_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/ana.25220","volume":"83","author":"E Seong","year":"2018","unstructured":"Seong E, Insolera R, Dulovic M, Kamsteeg E-J, Trinh J, Br\u00fcggemann N, et al. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects. Ann Neurol. 2018;83:1075\u201388.","journal-title":"Ann Neurol"},{"key":"2553_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/ana.25204","volume":"83","author":"J Gauthier","year":"2018","unstructured":"Gauthier J, Meijer IA, Lessel D, Mencacci NE, Krainc D, Hempel M, et al. Recessive mutations in VPS13D cause childhood onset movement disorders. Ann Neurol. 2018;83:1089\u201395.","journal-title":"Ann Neurol"},{"key":"2553_CR10","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1002\/mgg3.1108","volume":"8","author":"K Koh","year":"2020","unstructured":"Koh K, Ishiura H, Shimazaki H, Tsutsumiuchi M, Ichinose Y, Nan H, et al. VPS13D-related disorders presenting as a pure and complicated form of hereditary spastic paraplegia. Mol Genet Genomic Med. 2020;8:e1108.","journal-title":"Mol Genet Genomic Med"},{"key":"2553_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/cge.13713","volume":"97","author":"JS Lee","year":"2020","unstructured":"Lee JS, Yoo T, Lee M, Lee Y, Jeon E, Kim SY, et al. Genetic heterogeneity in Leigh syndrome: highlighting treatable and novel genetic causes. Clin Genet. 2020;97:586\u201394.","journal-title":"Clin Genet"},{"key":"2553_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/mdc3.13232","volume":"8","author":"JN Petry-Schmelzer","year":"2021","unstructured":"Petry-Schmelzer JN, Keller N, Karakaya M, Wirth B, Fink GR, Wunderlich G. VPS13D: One Family, Same Mutations, Two Phenotypes. Mov Disord Clin Pract. 2021;8:803\u20136.","journal-title":"Mov Disord Clin Pract"},{"key":"2553_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-0-444-64189-2.00012-3","volume":"155","author":"O Bereznyakova","year":"2018","unstructured":"Bereznyakova O, Dupr\u00e9 N. Spastic ataxias. Handb Clin Neurol. 2018;155:191\u2013203.","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"2553_CR14","first-page":"674","volume":"26","author":"J Lavie","year":"2017","unstructured":"Lavie J, Serrat R, Bellance N, Courtand G, Dupuy JW, Tesson C, et al. Mitochondrial morphology and cellular distribution are altered in SPG31 patients and are linked to DRP1 hyperphosphorylation. Hum Mol Genet. 2017;26(4):674\u201385.","journal-title":"Hum Mol Genet"},{"key":"2553_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.acthis.2017.03.001","volume":"119","author":"AJ Valente","year":"2017","unstructured":"Valente AJ, Maddalena LA, Robb EL, Moradi F, Stuart JA. A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. Acta Histochem. 2017;119:315\u201326.","journal-title":"Acta Histochem"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02553-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T07:02:48Z","timestamp":1644649368000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02553-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2553"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02553-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,12]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was received from the patient according to the declaration of Helsinki principles of medical research involving human subjects. Experiments were approved by the Comit\u00e9 de Protection des Personnes Bordeaux Outre-Mer III.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was received from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Durand received research support from the Association Strumpell-Lorrain (ASL).Pr Goizet received consulting fees from Overlord, honoraria for lectures from Sanofi Genzyme, Biomarin, Amicus, Biogen, financial support for research activities from Genzyme, Association Strumpell-Lorrain (ASL), Enroll HD, and inscriptions and travels for congresses were funded by Sanofi Genzyme, Amicus and Akcea.Dr. Trimouille received research support from the Fondation Maladies Rares (FMR).C Angelini, Dr. Michaud, Dr. Dellci and Dr. Coupry report no disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}